Found 1 articles for: "IL-17A Inhibitor Secukinumab"

Novel Regimen of IL-17A Inhibitor Secukinumab for the Remission of Severe Hidradenitis Suppurativa: Case Report

December 2022 | Volume 21 | Issue 12 | Case Reports | 1358 | Copyright © December 2022

Hidradenitis suppurativa (HS) is a morbid, recurrent skin condition that presents a major challenge to clinical therapy. Investigation into the pathogenesis of HS has implicated local and systemic pro...
Read More